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Introduction: The sympathetic activation is considered to be the main mechanism involved in the develop-
ment of cardiovascular diseases in obstructive sleep apnea (OSA). The heart rate variability (HRV) analysis
represents a non-invasive tool allowing the study of the autonomic nervous system. The impairment of HRV
parameters in OSA has been documented. However, only a few studies tackled the dynamics of the autonomic
nervous system during sleep in patients having OSA.
Aims: To analyze the HRV over sleep stages and across sleep periods in order to clarify the impact of OSA on
cardiac autonomic modulation. The second objective is to examine the nocturnal HRV of OSA patients to
find out which HRV parameter is the best to reflect the symptoms severity.
Methods: The study was retrospective. We have included 30 patients undergoing overnight polysomnography.
Subjects were categorized into two groups according to apneahypopnea index (AHI): mild-to-moderate
OSAS group (AHI: 530) and severe OSAS group (AHI30). The HRV measures for participants with low
apneahypopnea indices were compared to those of patients with high rates of apneahypopnea across the
sleep period and sleep stages.
Results: HRV measures during sleep stages for the group with low rates of apneahypopnea have indicated a
parasympathetic activation during non-rapid eye movement (NREM) sleep. However, no significant differ-
ence has been observed in the high AHI group except for the mean of RR intervals (mean RR). The para-
sympathetic activity tended to increase across the night but without a statistical difference. After control
of age and body mass index, the most significant correlation found was for the mean RR (p0.0001,
r0.248).
Conclusion: OSA affects sympathovagal modulation during sleep, and this impact has been correlated to the
severity of the disease. The mean RR seemed to be a better index allowing the sympathovagal balance
appreciation during the night in OSA.
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O
bstructive sleep apnea (OSA) is a common dis-
order affecting at least 24% of the adult popu-
lation (1, 2). It is characterized by the repetitive
complete or partial collapses of the pharyngeal airway
during sleep.
The diagnosis of OSA requires the presence of noc-
turnal and diurnal symptoms associated with an apnea
hypopnea index (AHI) greater than 5 events per hour on
polysomnography (PSG). The presence of 15 or more
obstructive respiratory events per hour of sleep in the
absence of symptoms is also sufficient for the diagnostic (1).
It is known that the risk of cardiovascular diseases
is increased in OSA (2, 3). The sympathetic activation is
considered to be the main mechanism involved in the
development of cardiovascular diseases (4, 5).
The heart rate variability (HRV) analysis represents
a non-invasive tool allowing the study of the autonomic
nervous system (6). HRV can be measured by different
methods. Time-domain, frequency (spectral)-domain, and
geometrical methods are the most common ones. In the
time-domain method, heart rate taken at any time or dis-
tance between consequent normal complexes is determined.
In the frequency-domain analysis, recordings are evaluated
either in 25 min or in 24-h time intervals. Frequency-
domain method is analyzed by studying the power spec-
tral density. It provides information about the power
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distribution across frequencies (6). Three main spectral
components are calculated.
The main two components are the low-frequency band
(LF) and the high-frequency band (HF). Some investiga-
tors have accepted the LF to be an indicator for sympa-
thetic activity. In contradiction, HF is determined by vagal
effect and respiratory sinus arrhythmia. The LF/HF ratio
has been derived from these values to show sympatho-
vagal balance (6). The HRV can be used as a marker of
autonomic modulation of the heart (7). A significant rela-
tionship between the HRV decrease and the cardiovas-
cular risk has been demonstrated and reported in several
diseases (8).
Several studies report a circadian rhythm of HRV.
In fact, compared to wakefulness, the heart rate of a
normal adult slows down during sleep (9, 10). However,
during rapid-eye movement (REM) sleep, the heart rate
does not differ significantly during the wake state, but
during non-REM (NREM) sleep, the heart rate decreases
progressively across the sleep periods. This pattern has
been associated with progressive sympathetic inhibition
during sleep, parasympathetic activation during NREM
sleep, and parasympathetic inhibition during REM sleep
(9). In patients presenting OSA, an imbalanced cardiac
autonomic function has been documented (1114).
Several studies have shown that the HRV analysis has
the potential of distinguishing the OSA severity. The HRV
has also been proposed as an alternative diagnostic tool
(15, 16). However, few studies tackled the dynamics of the
autonomic nervous system during sleep in patients having
OSA (9).
The aim of this study is to analyze the HRV over sleep
stages and across sleep periods in order to clarify the OSA
impact on cardiac autonomic modulation. The second
objective is to examine the nocturnal HRVof OSA patients
to find out which parameter in time- or frequency-domain
analysis is the best to reflect the severity of symptoms.
Methods
Study design
The study has been planned as a retrospective cohort
study.
Study population
Data of 141 male patients admitted in our sleep labora-
tory for snoring and PSG performed between the period
of January 2006 and March 2013 were analyzed.
The subjects met the following inclusion criteria: male,
aged between 18 and 60 years old, the apneahypopnea
index greater than 5 events per hour with clinical symp-
toms or only greater than 15 events per hour (1). The
choice of including men only was an aim to guarantee the
group homogeneity and due to the absence of information
concerning the female hormonal status (17, 18). Patients
known to have cardiovascular, renal, hepatic diseases,
thyroid dysfunction, diabetes, a history of endocrinopa-
thy or drug use that interact with the autonomic nervous
system, a history of operations or CPAP treatment for
OSA, periodic limb movements during sleep (PLMS),
were excluded from the protocol.
Basing on these criteria, we have analyzed the records
of 66 patients included in the protocol. At this stage, HRV
analysis has been performed in 30 patients with their
consent, excluding 36 cases having artifacts and ectopic
heart beats in their ECG or having less than three sleep
NREMREM cycles. The subjects were categorized into
two groups: mild-to-moderate OSA group (n16) and
severe OSA group (n14). The first has been defined
as subjects with an AHI ]5 and 530 and the latter as
subjects with an AHI 30 (1).
The following clinical data were recorded: the Epworth
Sleepiness Scale and the body mass index (BMI).
Polysomnography
Overnight PSG was performed using DeltaMed (France,
Coherence 4 NT) and Nihon Kohden (Japan, 2011) for
PSG performed after 2012. Sleep states were assessed by
recording biopotentials (electroencephalogram, electro-
myogram, electrooculogram), qualitative recordings of
respiratory effort (piezo sensors), airflow (thermal sen-
sors), and oxygen saturation (pulse oxymetry). The sampl-
ing frequency for the equipment DeltaMed was 256 Hz
and 500 Hz for Nihon Kohden.
Respiratory events were scored as follows: apnea has
been defined as a cessation of the airflow for more than
10 sec. Hypopneas have been defined as a reduction of
more than 50% of the oro-nasal flow amplitude during
10 sec, accompanied by 3% desaturation and/or arousal.
Hypopneas are classified as obstructive if there is evi-
dence of upper airway resistance such as snoring, para-
doxical motion in the respiratory bands, or inspiratory
flow limitation on nasal pressure signal (1).
Polysomnographic scoring and staging was based on
Rechtschaffen and Kales study, and episodes of arousals
were assessed according to the guidelines in the previous
studies (19).
HRV analysis
To study the HRV in different cycles, periods of 5 min
have been selected from REM sleep and NREM sleep
stages (represented by stage sleep 2 and slow wave sleep)
in each third of sleep period. Transitions between sleep
stages accompanied by sympathetic activation have been
avoided (20).
For each selected segment, the occurrence of obstruc-
tive respiratory events has been noted. The arousals have
been avoided (9). The selected segments of the ECG have
been extracted and converted into text files.
Electrocardiographic signals acquired by the polysom-
nographic machine were digitalized by the sampling rate
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of 256 Hz for DeltaMed equipment and 500 Hz for Nihon
Kohden equipment. The analysis of HRV was perfor-
med by the Kubios HRV (version 2.1, Finland) software
after research and correction of artifacts, in accordance
with the guidelines issued by the European Society of
Cardiology and The North American Society of Pacing
and Electrophysiology in 1996 (6).
Analyzed time-domain variables were mean RR and
RMSSD. Mean RR is the mean of RR intervals. RMSSD
is the square root of the mean of the sum of the squares of
differences between adjacent RR intervals. In frequency-
domain analysis, the power was calculated for very-low-
frequency (VLF, 0.00330.04 Hz), low-frequency (LF,
0.040.15 Hz), and high-frequency bands (HF, 0.15
0.40 Hz). The LF/HF ratio was also included in the statis-
tics. Normalized values of HF (nuHF) and LF (nuLF)
bands have been re-calculated using the formulas of
nuLFLF/HFLF and nuHFHF/HFLF.
Statistical analysis
Results were expressed as means (SD). When variables
showed a normal distribution, a one-way ANOVA was per-
formed, followed by a post hoc test. When variables were
not normally distributed, a non-parametric test for inde-
pendent samples was performed, followed by a Mann-
Whitney U test. Bivariate correlations were estimated with
Pearson or Spearman coefficients, as appropriate. A value
of pB0.05 two-tailed has been considered significant
with 95% confidence intervals.
Results
Clinical and PSG characteristics
The differences of mean age (3899.4 vs. 4297 years) and
BMI (2995 vs. 3095 kg/m) were not significant between
the mild/moderate and the severe OSA groups. As indi-
cated in Table 1, the two groups were comparable as far
as total sleep time, sleep efficiency, and the percentage
of sleep stage 2 are concerned. Compared with the mild/
moderate group, the severe OSA group had a higher stage
1 sleep, REM sleep percentage, a higher arousal index,
and a lower mean oxyhaemoglobin saturation as deter-
mined by pulse oxymetry (SpO2).
HRV analysis during sleep stages
In order to determine whether the heart rate autonomic
control differs significantly from wake base line for each
sleep stage, HRV indices for each sleep stage have been
compared to their corresponding wake and other sleep
stage measures.
Table 2 shows that with all participants pooled to-
gether, during S2, the mean RR increased in relation to
the wake stage accompanied with a significant increase
of HF and HFnu and a decrease of LFnu and LF/HF
ratio compared to REM sleep, the fact that reflects a para-
sympathetic activation and sympathetic inhibition during
NREM sleep.
No significant difference has been observed in the high
AHI group except for the mean RR which increased signi-
ficantly during NREM sleep compared to the wake stage.
Compared to mild/moderate group, the high AHI group
showed a significantly higher LFnu and LF/HF during S2
(p0.013, p0.008). The HFnu and HF were significantly
lower in the severe OSA group during S2 (p0.013).
During SP, the mean RR was higher in mild/moderate
group (p0.026). These results indicated a significant car-
diac deceleration during sleep stages in the mild/moderate
OSA group compared to high AHI group.
Figures 1 and 2 illustrate the profile of mean RR and
the LF/HF ratio along sleep stages.
The circadian effect
To study the variation of HRV indices along the night,
the sleep period has been divided into three parts. During
NREM sleep, the parasympathetic activity tends to in-
crease during the night (Fig. 3a and b). But it was not
significant. The same result has been observed during
REM sleep (Fig. 3c and d).
Apnea effect
By comparing the periods of 5 min, which are marked
by the occurrence of respiratory events, with those with-
out any obstructive respiratory event, we have found that
the RMSSD was significantly lower in the absence of
events (Table 3).
Correlation between the OSA severity and the
HRV indices during sleep
Bivariate correlation has been estimated first. In the overall
study group (n30), there was a negative correlation






SPT (min) 417952.4 426.65976.27 0.05
SE (%) 83.6996.62 78.199.27 0.05
SL (min) 13.2896.44 11.1097 0.05
Arl (total) 8.6796 15.798.22 0.015
S1 (%) 11.2693.8 16.599.6 0.03
S2 (%) 53.397.05 58.5399.3 0.05
S3S4 (%) 16.8695.54 9.4910.5 0.02
REM (%) 18.3493.6 15.298 0.02
Average SpO2 95.492.09 89.393.05 0.02
ODI 20.697.2 56.63922.2 0.02
OSA, obstructive sleep apnea; SPT, sleep period time; SL, sleep
latency; SE, sleep efficiency; S1, stage 1 sleep; S2, stage 2 sleep;
S3, stage 3 sleep; S4, stage 4 sleep; REM, REM sleep stage; AHI,
apneahypopnea index; ODI, oxygen desaturation event index;
ArI, arousal index.
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Table 2. Comparison of HRV indices during sleep stages and wake














Mean RR W 22 935.62915 0.03 WS2 13 9039148.5 0.03 S2W 9 797.9911 0.03 S2W
S2 73 975.65915 REMW 38 998.67916 35 950.589133.7 REMW
SWS 30 942.08914 19 956.41917 11 899.89100.6
REM 103 860914 57 969.69162 46 907.99998
RMSSD W 22 63.53943 0.05 13 52.5931.1 0.05 9 48.95943 0.05
S2 73 60.39943 38 54.45939 35 73.27945.63
SWS 30 65.16945 19 60.649513 11 59.97926.29
REM 103 51.02935 57 59.72941.9 46 71.9948.21
LF W 22 45.57917 0.05 13 47.24917.7 0.05 9 42.31924 0.05
S2 73 44.99917 38 41.88917 35 49.58916.38
SWS 30 50.47915.7 19 45.5919.68 11 44.01912.65
REM 103 45.22920.2 57 50.21915.4 46 50.79916.3
HF W 22 42.64920 0.02 S2REM 13 40.7917.16 0.01 S2REM 9 49.89929 0.05
S2 73 44.31921.2 38 48.37920 35 36.41920.22
SWS 30 34.50919.1 19 47.17922.8 11 39.36917.83
REM 103 44.46922.7 57 35.79918.7 46 32.9919.8
LFnu W 22 52.71920 0.018 REMS2 13 53.19919.2 0.02 S2BREM 9 47.36928 0.05
S2 73 51.71920.3 38 47.01920 35 58.91919.98
SWS 30 60.69919.1 19 49.84922.6 11 54.95916.19
REM 103 50.81923.2 57 59.43919.1 46 62.25919.2
HFnu W 22 47.18920 0.018 S2REM 13 46.27920.4 0.02 S2REM 9 47.36928 0.05
S2 73 48.2292.3 38 52.9920.0 35 40.97919.97
SWS 30 39.21919 19 50.09922.5 11 44.98916.18
REM 103 49.06923.2 57 40.48919.0 46 37.63919.2
LF/HF W 22 2.0790.4 0.018 REMS2 13 1.6290.8 0.02 REMS2 9 1.8790.6 0.05
S2 73 1.6490.3 REMSWS 38 1.6290.5 35 2.5690.5
SWS 30 2.8490.5 19 1.6790.38 11 2.8790.4
REM 103 1.7290.4 57 2.7190.6 46 3.0190.5
aHRV indices for each sleep stage were compared to their corresponding wake and other sleep stage measures by ANOVA test followed by post hoc test, when variables were normally




























































































between AHI and RR intervals (p0.042, r0.224), HF
(p0.001, r0.218) and HFnu (p0.001, r0.226).
A positive correlation has been found for LFnu
(p0.001, r0.225), LF (p0.017, r0.16) and LF/HF
ratio (p0.001, r0.226).
After adjustment of age and BMI, the most significant
correlation relationship found was for the mean RR
(Table 4).
Discussion
The main aim of this study was to test the hypothesis that
OSA was associated with an impaired cardiac autonomic
modulation over the night. The second hypothesis was
that HRV indices were affected by OSA severity.
Our results supported the first hypothesis. First, the
mild/moderate OSA group presented a parasympathetic
activation from wake to NREM sleep and a reversal to a
balance of less parasympathetic modulation during REM
sleep. This pattern is consistent with the findings of other
studies performed in healthy subjects about the cardiac
autonomic modulation along the sleep stages. These studies
showed a reduced sympathetic outflow and increased para-
sympathetic modulation shift from wake to NREM sleep,
a pattern reversed by entering in REM sleep (2125).
The changes in the sympathovagal balance could be
driven by oscillations in the metabolic demand during
sleep, which markedly decreases during deep sleep and in-
creases during REM sleep (26).
However, this shift of cardiac autonomic modulation
is impaired among OSA severe group which showed no
statistical difference between the sleep stages except for
the mean RR. Our data suggest a more parasympathetic
modulation reduction during sleep in the high AHI group.
These findings are similar to those reported by other
Fig. 1. Mean of the RR intervals (mean RR) profile across sleep stages. Error bars represent9standard error of the mean.
S2, sleep stage 2; SWS, slow wave sleep; REM, rapid-eye movement sleep; AHI, apneahypopnea index.
Fig. 2. The low frequency/high frequency (LF/HF) ratio profile across sleep stages. Error bars represent9standard error of the
mean. S2, sleep stage 2; SWS, slow wave sleep; REM, rapid-eye movement sleep; AHI, apneahypopnea index.
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studies (2729). Second, no statistically significant differ-
ence was found between the values of HRV indices across
the night. However, the parasympathetic activity tended
to increase with the progression of sleep during NREM
and REM sleep associated to the decrease of sympathetic
activity. These results suggest a circadian effect on the
autonomic nervous system and a better quality of sleep
reached progressively during the night. Several studies
reported a circadian rhythm of heart rate with lower levels
during the night compared to the day with a peak level at
awakening (10, 30). This rhythm is driven by an endoge-
nous central pacemaker located in the suprachiasmatic
nucleus of the hypothalamus (10).
Our results are consistent with the findings of some
studies performed during normal sleep which could not
identify a clear sympathovagal modulation across the
night (21, 25).
There are some data concerning the dynamic of HRV
of OSA patients during sleep. Our findings are partially
similar to those of Da Silva et al. (9) who showed a
significant cardiac deceleration during the last quartile
of the night, more pronounced in the high AHI group.
Fig. 3. Profiles of the mean of the RR intervals (mean RR) and the low frequency/high frequency (LF/HF) ratio for the different
parts of sleep period during NREM sleep (a, b) and REM sleep (c, d). Error bars represent9standard error of the mean.
Table 3. Comparison of HRV during free-event periods to





Mean HR 66.36910.82 65.2199.05 0.23
Mean RR 935.49162.28 950.889142.26 0.08
RMSSD 49.28932 73.2948.6 0.04
LF 47.24918.63 47.94915.86 0.4
HF 41.98921.04 38.2920.56 0.07
LFnu 53.61921.5 57.17920.06 0.08
HFnu 46.3921.49 42.72920.05 0.06
LF/HF 2.4190.3 2.2590.4 0.1
Table 4. Partial correlation of AHI and HRV indices control-
ling age and body mass index of the subjects with obstructive
sleep apnea
Variable p rp
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A mechanism of parasympathetic overcompensation was
evoked. This mechanism was associated with the increase
of hydraulic pressure and the stimulation of carotid
aortic chemoreceptor in response to apnea (9).
The second hypothesis of this study was that HRV indi-
ces were correlated to the severity of OSA. A significant
but small correlation was found for the frequency HRV
parameters. Most of the temporal indices failed to show
a significant correlation except for the mean RR. After
control of age and BMI, the mean RR was found to be
the most affected by AHI. Our results are partially similar
to those of Zhu et al. (31) who found a negative correla-
tion with the mean RR, suggesting it to be the best index
to assess the sympatheticparasympathetic balance over
the night in OSA. However, no statistical difference was
found for the spectral indices in their study. In some other
previous studies, LF/HF was found to present the most
significant correlation with the AHI (28, 32, 33).
Limitations
This study is one of few that have assessed the HRV by
sleep stage and at the different parts of night with the
presence of sleep apnea syndrome. However, it presents
quite a few limitations. It is a retrospective study with a
reduced sample. The interpretation of HRV parameters
during the wake period may be biased due to the lack of
control over environmental factors. The population study
was based only on men, therefore not allowing a study
of the differences according to gender. The choice of
including men only has been previously explained.
One of the main limits of our study concerns measure-
ment conditions of HRV during sleep.
The spectral study requires the respect of the signal
stationary condition, which should vary little through time.
Respecting this condition becomes an issue when studying
parameters during sleep with the presence of OSA (14).
Indeed, apnea induces tachycardia during arousal proceed-
ing by reinforcement of respiratory sinus arrhythmia (14).
Measuring the HRV during this period does not respect
the stationary condition. In spite of this, some authors
have studied the effect of the respiratory events on HRV
like Guilleminault et al. (34) who have found a significant
increase of LF/HF and decrease of HF after the event.
Some other authors have chosen to study the HRV
during the periods without respiratory events (28). This
choice is also problematic because it is very hard for some
patients to find free-event periods, without mentioning
the risk of not scoring subclinical events (14).
The objective of this work was to study the modulation
of the HRV parameters during different sleep stages at
night aiming for studying the dynamics of the autonomous
nervous system during the sleep cycles. It was difficult
to find periods without respiratory events with a number
of patients. These periods were included, while noting
the onset of the obstructive events. The comparison of
obstructive events with those without it shown in the
RMSSD was significantly higher in the presence of
respiratory event.
The increase of the RMSSD, which habitually testifies
to the reinforcement of the parasympathetic nervous acti-
vity modulated by respiration, may be attributed to modi-
fications in the cardiac rhythm that accompany these
episodes. Its inability to distinguish between increasing
HRV due to an erratic rhythm and an increase in para-
sympathetic activity makes it problematic and not reflec-
tive of the parasympathetic nervous system (14).
No other statistical difference was found including the
mean RR. This may be attributed to the presence of no
scored subclinical events.
Conclusion
This study is one of the few investigating the HRV by
sleep stage at different parts of night with the presence
of OSA. It shows the effects of OSA on sympathovagal
modulation during sleep and this impact was correlated
to the severity of the disease.
The mean RR seemed to be a better index allowing the
sympathovagal balance appreciation during night in the
OSA. Our findings could be used further to confirm
the contribution of HRV parameters as a screening tool
in the OSA.
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